tiprankstipranks
Advertisement
Advertisement

COYA Stock Latest News

Coya Therapeutics initiates first cohort of patients in ALSTARS trial
The FlyCoya Therapeutics initiates first cohort of patients in ALSTARS trial
2d ago
COYA
Coya Therapeutics initiated with a Buy at Roth Capital
PremiumThe Fly
Coya Therapeutics initiated with a Buy at Roth Capital
5d ago
COYA
Coya Therapeutics Establishes $30 Million ATM Equity Program
PremiumCompany Announcements
Coya Therapeutics Establishes $30 Million ATM Equity Program
29d ago
8K
COYA
Coya Therapeutics Updates Q1 Results, COYA 302 Progress
PremiumCompany Announcements
Coya Therapeutics Updates Q1 Results, COYA 302 Progress
29d ago
8K
COYA
Coya Therapeutics granted FDA Fast Track Designation for COYA 302
PremiumThe Fly
Coya Therapeutics granted FDA Fast Track Designation for COYA 302
29d ago
COYA
Coya Therapeutics reports Q1 EPS (32c), consensus (39c)
PremiumThe FlyCoya Therapeutics reports Q1 EPS (32c), consensus (39c)
29d ago
COYA
Coya Therapeutics announces publication of research on COYA 302
Premium
The Fly
Coya Therapeutics announces publication of research on COYA 302
2M ago
COYA
Coya Therapeutics Announces Leadership Changes and New Director
Premium
Company Announcements
Coya Therapeutics Announces Leadership Changes and New Director
2M ago
8K
COYA
Coya Therapeutics Executive Chairman Howard Berman steps down
PremiumThe Fly
Coya Therapeutics Executive Chairman Howard Berman steps down
2M ago
COYA
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
3M ago
COYA
CTMX
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
PremiumRatings
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
3M ago
COYA
Coya publishes study showing reduction in regulatory T cell function in FTD
PremiumThe Fly
Coya publishes study showing reduction in regulatory T cell function in FTD
3M ago
COYA
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
PremiumRatingsAggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
3M ago
COYA
Coya Therapeutics Announces Strategic Private Placement Financing
Premium
Company Announcements
Coya Therapeutics Announces Strategic Private Placement Financing
4M ago
8K
COYA
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
Premium
The Fly
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
4M ago
RDY
COYA
Coya Therapeutics Reports Strong Cash Position and Runway
PremiumCompany Announcements
Coya Therapeutics Reports Strong Cash Position and Runway
5M ago
8K
COYA
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
PremiumRatings
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
5M ago
COYA
Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating
PremiumRatings
Coya Therapeutics: Early COYA 302 Validation, Regulatory De-Risking, and Upcoming Catalysts Support Buy Rating
5M ago
COYA
Coya Therapeutics Reports Positive Frontotemporal Dementia Study Data
PremiumCompany Announcements
Coya Therapeutics Reports Positive Frontotemporal Dementia Study Data
5M ago
8K
COYA
Coya Therapeutics announces FDA acceptance of COYA 302 IND application
PremiumThe FlyCoya Therapeutics announces FDA acceptance of COYA 302 IND application
5M ago
COYA
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
Premium
Ratings
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
5M ago
COYA
Coya announces Health Canada acceptance of COYA 302 clinical trial application
Premium
The Fly
Coya announces Health Canada acceptance of COYA 302 clinical trial application
6M ago
COYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >